Galapagos’ Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients
Galapagos NV (NASDAQ:GLPG) announced results of two post-hoc analyses from the SELECTION and SELECTION LTE studies of filgotinib for active ulcerative…
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 4)
Galapagos Reports Results From 2 Post Ad-Hoc Analyses From SELECTION, SELECTION LTE Studies At United European Gastroenterology Week Congress Oct. 3-5, 2021
Scientific Games Corporation (NASDAQ:SGMS) ("Scientific Games" or the "Company") announced it won a 10-year base contract from the Pennsylvania Lottery (or the "Lottery") to
Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn’s Disease
Galapagos NV (NASDAQ:GLPG) has randomized the last patient into the DIVERSITY Phase 3 study of filgotinib in the induction and maintenance…
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 30)
The Daily Biotech Pulse: AbbVie’s Migraine Drug OK’d By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 28)
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 20)
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 20)
Galapagos Reports Positive CHMP Opinion For Jyseleca For Treatment Of Adults With Moderately To Severely Acute Ulcerative Colitis
Galapagos NV ((Euronext &, NASDAQ:GLPG) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca®
